Sign in
8-K

Current Report

X4 Pharmaceuticals, Inc Filed Acc 0001193125-22-009865

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d263241d8k.htm…